JP Patent

JP7117975B2 — テネリグリプチン含有医薬組成物、テネリグリプチン含有医薬組成物の製造方法、テネリグリプチン含有錠剤及びテネリグリプチン含有錠剤の製造方法

Assigned to Sawai Pharmaceutical Co Ltd · Expires 2022-08-15 · 4y expired

What this patent protects

Patent listed against venlafaxine-besylate.

Drugs covered by this patent

venlafaxine-besylate (VENLAFAXINE BESYLATE)

Patent Metadata

Patent number: JP7117975B2
Jurisdiction: JP
Classification: —
Expires: 2022-08-15
Drug substance claim: No
Drug product claim: No
Assignee: Sawai Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.